GE Healthcare

At GE Healthcare we realise that Molecular imaging is unique. With its ability to make visible what would otherwise be invisible, it can reveal deeply hidden truths about the human body. The kind of truths that could save the life of one patient, or transcend an individual to benefit all patients. We call this a true discovery.

Our mission is to help you find your next true discovery by pursuing a fully digital molecular imaging experience and by being adaptable to your needs. No matter what molecular imaging technology you choose, we want you to have the tools you need to go in search of true discovery. At GE Healthcare we are developing solutions for today’s imaging and tomorrow’s diagnosis and treatment monitoring for the Theranostics Imaging developments to provide complete solutions for your patients.

When we set out to help make SPECT/CT the essential clinical tool we believed it could be, we perceived only a glimmer of its potential. Today, we continue to be in awe as we watch you use this technology every day to better diagnose your patients and to further your own clinical research.

The 800 Series reflects our continued commitment to helping improve the quality, access and affordability of SPECT/CT, so you can continue in your work to change lives for the better.

To celebrate this true partnership in true discovery, we’re introducing the 800 Series. This new family of five nuclear medicine systems puts into practice everything we’ve learned over the course of 20 years by bringing the latest in SPECT/CT advancements to a wider range of clinical environments. Along with the breakthrough CZT-based NM/CT 870 CZT, the digital-ready NM/CT 870 DR and the SPECT-only NM 830, the 800 Series includes two eight-slice CT hybrids. NM/CT 850 and NM/CT 860. We strategically paired these two systems with CT technology that makes state-of-the-art CT performance accessible to practices with emerging or more routine hybrid needs.

To learn more, contact Len by email to book an immediate appointment (

Alternatively, please join this Microsoft Teams meeting to speak to someone immediately


800 Series Brochure MotionFree Clinical Benefits Infographic

GE Healthcare,
Chalfont St Giles, Buckinghamshire, UK

Leonard Squance, Modality Manager UK&I
Join a Microsoft Teams Meeting


© 2013 BNMS unless otherwise stated.
The BNMS is a registered as a company in England and Wales with number 08082786.  The BNMS is a charity governed by the rules of the Charity Commission for England and Wales - Registered Number 1150234.  Registered Office: The Royal College of Physicians, 11 St. Andrew's Place, Regent's Park, London NW1 4LE.
The British Nuclear Medicine Society is not able to give specific clinical advice to members of the public. If you are concerned about your scan or therapy please seek the opinion of a nuclear medicine clinician where you were seen or the clinician who referred you to the department or your GP.
Enquiries related to issues such as internships and work experience opportunities, should be directed to the relevant professional body e.g., for radiologists, this will be the Royal College of Radiologists.